logo

Pfizer Inc. (PFE)



Trade PFE now with
  Date
  Headline
1/14/2019 8:01:49 AM Pfizer : FDA Accepts Regulatory Submissions For Review Of Tafamidis To Treat Transthyretin Amyloid Cardiomyopathy
1/7/2019 8:08:50 AM CytoReason Signs Deal With Pfizer To Utilize CytoReason’s Machine Learning Model Of Immune System For Drug Discovery
1/3/2019 8:33:35 AM Pfizer Begins Phase 2b/3 Clinical Trial For Oral JAK3 Inhibitor, PF-06651600
12/20/2018 9:06:44 AM Astellas And Pfizer Announce Results From Phase 3 ARCHES Trial Of XTANDI
12/19/2018 2:03:14 AM GlaxoSmithKline And Pfizer To Form New Consumer Healthcare JV
12/17/2018 8:03:20 AM Kineta Enters Strategic Research Collaboration With Pfizer
12/14/2018 12:24:07 PM Pfizer Inc. (PFE) Announces $10 Bln Stock Buyback
12/14/2018 12:23:25 PM Pfizer Inc. (PFE) Declares $ 0.36 Dividend for Q1 19, Record Date 2/1/2019
12/14/2018 12:10:56 PM Pfizer Declares Q1 Dividend Of $0.36, Payable March 1/ Record Feb. 1
12/14/2018 8:00:59 AM Pfizer Initiates Phase 3 Program For 20-Valent Pneumococcal Conjugate Vaccine